feed,title,long_url,short_url
SeekingAlpha,AnaptysBio fails in mid-stage study for Imsidolimab in skin disease,https://seekingalpha.com/news/3670276,
SeekingAlpha,AIM Immunotech starts dosing in early-stage intranasal ampligen study,https://seekingalpha.com/news/3670275,
SeekingAlpha,On the hour,https://seekingalpha.com/news/3670274,
